Beyond the buzz...
Having worked at the intersection of digital and pharma since 2008 (before it was sexy), I've had the opportunity to engage many talented...
Blackletter
Group
- 2 min
why should we invest in digital?
“Why should we invest in a digital therapeutic when it will never come close to generating the revenue we make from our drug portfolio?...
- 2 min
digital health is losing credibility
“It’s been 3 years of strategizing, ideating and experimenting with very little impact - unfortunately, our digital health folks have...
- 2 min
specificity wins the day!
Imagine going for a hike and accidentally falling into a deep hole you can’t climb out of. You look up but all you see is blue sky and...
- 1 min
do digital therapeutics work?
I’ve noticed a significant increase in conversations about how to best evaluate the efficacy of digital therapeutics (e.g., do they...
- 2 min
"ai" is so much hype...
“Miron, these AI tools aren’t doing the things we want them to do” I love separating hype from what’s real and a recent dinner with a...
- 2 min
can digital health scale?
“We worked on a digital health project that was moving at lightning speed with a small team, and at some point, we shared it with the...
- 2 min
finding "deep edge"
I've recently noticed more tech scouting requests come in from of our Pharma clients. What's interesting is that while they often have...
- 1 min
medical affairs and digital affairs
“The pandemic has made it more difficult to engage with physicians in a meaningful way. Sending them a pdf of our recent study and...
- 2 min
using ai for bad...
What happens when AI drug discovery tools are (mis)used to find the most lethal human toxins instead of new therapies? In this “thought...